Spinnovation expands into the US
Spinnovation announces that it further anchors its presence in the US market through the collaboration with Quantum Tessera in Collegeville, Pennsylvania. This exciting extension to the business came after the Company trebled the number of clients in the biotech and pharma markets last year. Dr Edward Zartler from Quantum Tessera, will be working with Spinnovation to develop biologic and biosimilar characterisation markets in the US.
Dr Frederic Girard, CEO of NMR services specialist Spinnovation said “The new presence in the US has enabled us to take advantage of the expanding interest in bioprocess technologies to support the manufacture of biologics. We are gaining momentum with new companies in new markets, and are very excited to see what the future holds.”
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.